|
Showing 1 - 2 of
2 matches in All Departments
This thesis outlines the development of the very first technology
for high-throughput analysis of paired heavy and light-chain
antibody sequences, opening an entirely new window for antibody
discovery and the investigation of adaptive immune responses to
vaccines and diseases. Previous methods for high-throughput immune
repertoire sequencing have been unable to provide information on
the identity of immune receptor pairs encoded by individual B or T
lymphocytes. The author directly addresses these limitations by
designing two new technologies for sequencing multiple mRNA
transcripts from up to 10 million isolated, single cells. The
techniques developed in this work have enabled comprehensive
interrogation of human B-cell repertoires and have been applied for
rapid discovery of new human antibodies, to gain new insights into
the development of human antibody repertoires, and for analysis of
human immune responses to vaccination and disease.
This thesis outlines the development of the very first technology
for high-throughput analysis of paired heavy and light-chain
antibody sequences, opening an entirely new window for antibody
discovery and the investigation of adaptive immune responses to
vaccines and diseases. Previous methods for high-throughput immune
repertoire sequencing have been unable to provide information on
the identity of immune receptor pairs encoded by individual B or T
lymphocytes. The author directly addresses these limitations by
designing two new technologies for sequencing multiple mRNA
transcripts from up to 10 million isolated, single cells. The
techniques developed in this work have enabled comprehensive
interrogation of human B-cell repertoires and have been applied for
rapid discovery of new human antibodies, to gain new insights into
the development of human antibody repertoires, and for analysis of
human immune responses to vaccination and disease.
|
You may like...
Ab Wheel
R209
R149
Discovery Miles 1 490
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.